Exelixis

IPO

Shaping the Future of Oncology for Patients l Exelixis

Public · Alameda, United States · Founded 1994

Employees
1001–5000
Founded
1994
Business Model
B2B
Type
Public

About

Oncology-focused biopharmaceutical company developing cancer treatments, including cabozantinib, through internal development and strategic partnerships.

Summary

Exelixis is a Biotech company based in Alameda, United States, founded in 1994.

Tech & App Stack

5 technologies & apps tracked

Create a free account — 25 credits a month to unlock the full tech & app stack, funding history, and valuations.

Sign up to view the funding chart

Create a free account — you'll get 25 credits a month to unlock funding history, valuations, and tech stacks.

Funding History

IPOApr 2000
$118.0M

Similar Companies